Although there are tons of diet pills out on the market today, many people question which diet pills really work and which ones are complete phonies! Dietary pills can not only be very effective but they can also speed your weight loss total up by weeks. Many of the dietary pills also claim to provide you with an instant 10 pound loss in just 7 days… all without the hassle of counting out calories and portions.
 
Although keep in mind that as with any type of diet option, exercise is a must! We have researched every aspect of dietary pills and have come up with a list of dietary pills that have been proven to work and carry the least amount of side effects. Although, like we have said before, you will want to check with your doctor before you start taking any type of weight loss medication.
Below are some of the top rated dietary pills that many have found to be an instant success in their weight loss venture to eliminating up to 10 pounds in just a week.
 
Tenuate – is one type of dietary pill that is very good for short term weight loss. Not only is this a fast acting dietary pill but it also helps eliminate and burn fat even if you don’t exercise. However, like I said before after a few weeks of using the dietary pill you will slowly see its results diminish…. However with a continued well balanced and healthy diet you can now maintain your newly acquired figure.
 
Unique Hoodia – is another type of dietary pill that aids in the suppressing your hunger as well as your appetite. Although, unlike most dietary pills, Unique Hoodia contains absolutely no chemicals that are said to give harm to your body. Many people have found that using Unique Hoodia, even without the aid of exercising, has given them the chance to reach their weight loss goal of 10 pounds in one week very effectively. Unique Hoodia is said to be one the most powerful fat burning dietary pills on the market today!
 
Proactol – is another dietary pill where there is no exercise involved. Proactol works to fight off excess fat that is stored in different areas of your body. Proactol is also an all-natural dietary pill that has little to no side effects. In this particular dietary pill it also aids in the suppression of hunger as well as appetite and many people have found to be an instant success in losing that much needed 10 pounds in 7 days. Although, Proactol is not recommended for anyone with health conditions such as diabetes or if you experience frequent kidney problems.
 
Apidexin – is yet another diet pill that helps aids your hunger and appetite as well as burns stored fats. Many obese people find this to be a very helpful diet pill and find they are losing weight at an incredible rate. However, many physicians as well as people that have taken this diet pill before, strongly advise that you do not take the medication for more than a 3-4 month period.
 
Lipo 6 Black – Not only does this diet pill aid in the suppression of hunger and appetite is also enhances a person’s energy level. This diet pill is proven to be a fast acting fat burner and many have produced results of more than 8 pounds per week when using Lipo 6 Black. Although it does carry minor side effects, they cause no organ harm to your body.
 
MAN Vaporize – this diet pill not only has fast acting fat burning characteristics but it also blocks any fat from absorbing and being stored in your body. MAN Vaporize has also been proven to lower cholesterol levels dramatically because of its fast acting fat burning properties. This particular diet pill also aids in maintaining the performance of your kidneys as well as protects them from any type of harm during the course of using MAN Vaporize. Many people have found this diet pill to be majorly affective in the aid to losing up to 10 pounds in a week.
 
Phentermine – is also a very powerful fat burning fat burning diet pill. This diet pill curbs your appetite and therefore limits the intake of food. This diet pill has to be prescribed by your doctor as well as weight management should be performed while taking this particular diet pill. Many people find the effectiveness of Phentermine very successful and many only have to take the medication for 1 month to reach even a staggering 35 pound weight loss goal! WOW! Many people have also reported to losing the most amount of weight in just the first week of taking Phentermine… some of which over a 10 pound loss in weight!
 
Although many people find other means of losing weight without the aid of diet pills, many people find that taking diet pills helps them reach their weight loss goal quicker as well as more effectively. When it comes to whether or not to take a diet pill depends on the person solely. Like we said before weigh out your pros and cons and speak with your medical provider to make sure that diet pills are right for you. The diet pills listed above have been voted as the top diet pills on the market today and have been proven to effectively give a person the weight loss goal that they are looking for.
 
As for losing 10 pounds in 7 days by using diet pills, some have found it effective while others have found that it takes them a couple days longer to acquire such a weight loss. Diet pills may just be your ticket to the 10 pound weight loss you are looking for and can produce a slimmer and better looking body that people would kill for!

Arena Pharmaceuticals, Inc. and Eisai Inc. announced late September 2011 that new data analyses from the lorcaserin Phase 3 clinical trial program will be presented in poster sessions at Obesity 2011, the 29th Annual Scientific Meeting of The Obesity Society in Orlando, Florida.

Arena submitted a New Drug Application (NDA) for lorcaserin to the FDA in December 2009, and the FDA issued a Complete Response Letter (CRL) in October 2010.

Arena’s wholly owned subsidiary, Arena Pharmaceuticals GmbH, has granted Eisai Inc. exclusive rights to market and distribute lorcaserin in the United States subject to FDA approval of the lorcaserin NDA.

Lorcaserin is an investigational drug candidate intended for weight management, including weight loss and maintenance of weight loss, in patients who are obese (BMI >/= 30) or patients who are overweight (BMI >/= 27) and have at least one weight-related co-morbid condition. Lorcaserin is a new chemical entity that is believed to act as a selective serotonin 2C receptor agonist. The serotonin 2C receptor is expressed in the brain, including the hypothalamus, an area believed to be involved in the control of appetite and metabolism.

In July 2010, Vivus’s experimental diet drug Qnexa was rejected by the advisory committee.

That was followed in September 2010 with the FDA advisory committee recommending against the approval of an experimental weight-loss drug Lorcaserin. On the question of whether the benefits of the drug outweigh the risks when used long-term for a population of overweight and obese individuals, 5 committee members voted yes and 9 voted no.

This month, October 2011, drug developer Vivus Inc. has resubmitted an application for its potential weight-loss drug Qnexa to the FDA (Food and Drug Administration).

The resubmission follows an agreement on filing strategy that it reached last month with representatives of the FDA’s Endocrine and Metabolic Division.

Qnexa has been touted by many experts as the most promising weight-loss drug in more than a decade. But the FDA declined to approve it last year and had asked Vivus Inc. to look into the risk of birth defects in women who use Qnexa ingredient topiramate as a migraine treatment.

The company met with the FDA earlier this year to discuss studying existing electronic health care databases to assess birth defects in the children of women who were exposed to topiramate during pregnancy. Vivus has said it agreed with the FDA on the study’s design, goals and eligibility criteria.

The resubmission seeks approval for the treatment of obesity for obese or overweight patients with conditions like hypertension or type 2 diabetes. Proposed labeling for the drug includes a contraindication for women who could potentially become pregnant.

The FDA panel Voted against the Obesity Drug Qnexa yesterday.

The advisory committee voted 10 to 6 against endorsing the weight loss drug Qnexa, signaling heightened concerns for possible health risks associated with a new generation of diet pills.

The F.D.A. is scheduled to decide by late October whether to approve Qnexa. It usually abides by the advice of its advisory committees.

The outcome of the advisory committee meeting on Qnexa could also mean a more difficult time for two other new weight loss drugs that will face advisory committee hearings this year. These are Lorcaserin from Arena Pharmaceuticals and Contrave from Orexigen Therapeutics.

We keep you posted here.

A new report support that Arena Pharmaceuticals Inc.’s lorcaserin prompted weight loss without heart-related side effects.

The study showed that lorcaserin caused more people to lose at least 5 percent of their body weight over one year, or more than double the rate of placebo. The results will be in Thursday’s New England Journal of Medicine.

Lorcaserin weight loss drug is one of three potential obesity drug blockbusters that could reach the market over the next several years.

Qnexa weight loss drug receives FDA approval this week (see previous post).

Contrave, the third weight loss drug is up for FDA review in December.

All signs are that Qnexa weight loss drug receives FDA approval tomorrow.

According to a report released today by the U.S. Food and Drug Administration, a potential new obesity drug appears effective at helping patients lose weight.

There are concerns about side effects — which could include depression, anxiety, impact on heart rate and risks for pregnant women.

FDA advisory committee meeting scheduled for Thursday, could open the door toward FDA approval for the drug which would be marketed as Qnexa.

in trials participants taking Qnexa lost significantly more weight than those taking a placebo, and those taking the highest doses of the drug lost the most weight.

The FDA report can be read HERE (PDF file)

The potential market for drugmaker Vivus’ experimental Qnexa is huge. More than two-thirds of American adults are overweight or obese. Vivus wants to market Qnexa for adults to use along with diet and exercise. FDA staff reviewers said Qnexa clearly helped people shed pounds but pointed to possible side-effect issues, such as the impact on heart rate, depression and pregnancy.

In the report weight loss averaged 3.2%, 6.7% and 8.9% from body weight over the placedo group for the low, mid and high dose of the Qnexa drug.

We keep you updated on the outcome.

Federal health advisers will scrutinize Vivus’s highly anticipated weight loss drug. Vivus has asked the Food and Drug Administration to approve its experimental drug Qnexa for patients with obesity. A panel of FDA advisers will vote on the safety and effectiveness of Vivus’ drug coming Thursday.

The potential market for an anti-obesity drug estimates into billions. But most prior therapies have been plagued by lackluster results and serious side effects.

Avianda, a previous obesity drug marketed by GlaxoSmithKline, is also under discussion since studies suggested ties to heart attacks.

Qnexa showed weight loss results in clinical trials, with patients losing between 13 percent and 15 percent of their body weight. But the drug also had an high rate of patient dropouts due to side effects, which include memory and concentration problems.

We keep you up-to-date.